Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-05

FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves a generic fixed-dose combination of amlodipine and benazepril hydrochloride for hypertension (ANDA 202239) by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Benazepril Hydrochloride (Amlodipine and Benazepril Hydrochloride)

Snippet

ORIG AP for AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE)